MedPath
FDA Product

Arixtra

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Arixtra

67457-592

Regulatory Information

67457-592

NDA021345

C73594

June 8, 2020

USA

These highlights do not include all the information needed to use ARIXTRA safely and effectively. See full prescribing information for ARIXTRA. ARIXTRA (fondaparinux sodium injection), for subcutaneous useInitial U.S. Approval: 2001

HUMAN PRESCRIPTION DRUG LABEL

11

Company Information

790384502

Active Ingredients

FONDAPARINUX SODIUM

Quantity: 2.5 mg in 0.5 mL

Code: X0Q6N9USOZ

Class Code: ACTIB

SODIUM CHLORIDE

Code: 451W47IQ8X

Class Code: IACT

WATER

Code: 059QF0KO0R

Class Code: IACT

SODIUM HYDROXIDE

Code: 55X04QC32I

Class Code: CNTM

HYDROCHLORIC ACID

Code: QTT17582CB

Class Code: CNTM

Active Moieties

FONDAPARINUX

Code: J177FOW5JL

© Copyright 2025. All Rights Reserved by MedPath